|
|
|
Available: 0 |
List Price:$319.00 |
|
Other formats:
|
Edition: | 1st |
Publisher: | Springer Nature |
ISBN: | 3-7643-7174-9 (3764371749) |
ISBN-13: | 978-3-7643-7174-6 (9783764371746) |
Binding: | Hardcover |
Copyright: | 2005 |
Publish Date: | 11/05 |
Volume: | 63 |
Weight: | 2.14 Lbs. |
Pages: | 303 |
Subject Class: | ONC (Oncology) |
Remarks: | Please allow additional 3-4 days for delivery |
Return Policy: | Returns accepted up to 12 months provided no other recalls or return restrictions apply. |
Table Of Contents: |
View
|
Contributing Authors: |
View
|
ProQuest Ebook Central: |
Available in ProQuest Ebook Centralâ„¢ View
|
|
|
|
ISSN Series: | Progress in Drug Research | Discipline: | Pathology | Subject Definition: | Neoplasms-Therapy | NLM Class: | QZ 266 | LC Class: | RC270.8 | Abstract: | This volume covers the general topic of targeted cancer therapy. It presents a range of targets such as tumor angiogenesis, cell cycle control and cell signalling, COX-2, apoptosis/cell survival, invasion and metastasis and approaches like kinase inhibitors, antisense, and antibody-based therapeutics. The emphasis is on preclinical development, including target validation, development of biomarkers, strategies for combination approaches, and development of resistance. The particular challenges involved in translating these data to clinical application are discussed. This volume should be of broad general interest to researchers and clinicians involved in cancer therapy as well as other scientists interested in current strategies for cancer treatment. |
|
|
|
|
|
|
Follow Matthews Book Co. on:
Copyright © 2001-2024 Matthews Book Company - All rights reserved. - 11559 Rock Island Ct., Maryland Heights, MO, 63043 - (800) MED-BOOK
Matthews